Pfizer wants approval for its Covid booster for children over 5 years old
Pfizer asked U.S. regulators Monday to expand the use of its updated Covid-19 booster shot to children ages 5 to 11.
Pfizer asked U.S. regulators Monday to expand the use of its updated Covid-19 booster shot to children ages 5 to 11.
Elementary school-aged children already received kid-sized doses of Pfizer’s original vaccine, a third of the dose given to everyone 12 and older — two primary shots plus a booster.
If the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it was time for their booster.
FDA vaccine chief Dr. Peter Marks said last week he expected a decision on boosters for that age group soon.
Pfizer and its partner BioNTech also announced a new study of the omicron-focused booster in even younger children, those ages 6 months through 4 years, to test different doses.
Rating: 5